Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

N/AUnknownNCT00912067

Sheba Medical Center120 enrolled

Overview

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Graft Versus Host Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * after hematopoietic stem cell transplantation done at sheba medical center Israel * 3 month have past from transplantation but no more then 3 years Exclusion Criteria: * transplantation done in the last 3 month or more than 3 years have past since

Locations (1)

Sheba Medical Center

Tel Litwinsky, Israel

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.